This review focuses on how thioredoxin-1 (TXN1), thioredoxin reductase-1 (TXNRD1), and members of the protein disulfide isomerase (PDI) family regulate thiol-disulfide balance at the cancer cell surface and how these alterations can be exploited for theranostic applications. Here, P4HB is linked to cancer.